Schoch Charles 4
4 · Candel Therapeutics, Inc. · Filed Jun 24, 2025
Insider Transaction Report
Form 4
Schoch Charles
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-06-20+50,000→ 50,000 totalExercise: $4.75Exp: 2035-06-20→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]This option is subject to time-based vesting. 25% of the shares underlying this option shall vest and become exercisable on June 20, 2026, with the remainder vesting in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.